FDA Adverse Event
Death
Summary report: N
REFOBACIN PLUS BONE CEMENT 40
MDR report key: 5262904
·
Received December 3, 2015
Report
- Report Number
- 3002806535-2015-04114
- Event Type
- Death
- Date Received
- December 3, 2015
- Date of Event
- November 2, 2015
- Report Date
- November 25, 2015
- Manufacturer
- BIOMET FRANCE S.A.R.L
- Product Code
- LOD
- PMA / PMN Number
- PN/A
- Removal / Correction Number
- N/A
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SZ
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
Additional Manufacturer Narrative · 1
THIS USER FACILITY IS OUTSIDE OF THE UNITED STATES. CURRENT INFORMATION IS INSUFFICIENT TO PERMIT A CONCLUSION AS TO THE CAUSE OF THE EVENT. REVIEW OF DEVICE HISTORY RECORDS SHOW THAT LOT RELEASED WITH NO RECORDED ANOMALY OR DEVIATION. THIS PRODUCT IS MANUFACTURED BY ZIMMER BIOMET (B)(4) AND IS NOT CLEARED OR DISTRIBUTED IN THE U.S. HOWEVER, THIS REPORT IS BEING SUBMITTED AS ZIMMER BIOMET IN (B)(4) MANUFACTURES A SIMILAR DEVICE IN THE UNITED STATES UNDER 510K NUMBER K051496.
Description of Event or Problem · 1
IT WAS REPORTED PATIENT UNDERWENT AN UNKNOWN PROCEDURE ON (B)(6) 2015. DURING THE PROCEDURE, THE PATIENT EXPIRED DUE TO LIPEMIC EMBOLISM AFTER THE CEMENTATION OF THE PROSTHESIS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 794251 | REFOBACIN PLUS BONE CEMENT 40 | BONE CEMENT | LOD | BIOMET FRANCE S.A.R.L | N/A | A503AK1833 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR | Death |